Sports Data Labs Expands AI Patent Portfolio with Groundbreaking U.S. Patent for Athlete Data Simulation System
Sports Data Labs, Inc. (SDL), a trailblazer in AI-driven human data collection, analysis, and distribution, has announced the issuance of U.S. Patent No. 12,330,047 by the United States Patent and Trademark Office (USPTO). This latest patent significantly expands SDL’s intellectual property portfolio across high-growth sectors such as human performance, longevity, eSports, and sports betting. The newly issued patent covers an innovative AI-based system and method for generating synthetic biological data to simulate biological processes in athletes—spanning humans, racehorses, and digital representations—and predict future events with remarkable precision.
A Novel Approach to Predicting Future Biological States
The patented system, titled “System for Generating Simulated Animal [Human] Data and Models,” leverages advanced neural networks trained on captured biological sensor data, contextual information, modifiable variables, and personal medical data. By synthesizing this information, the system generates artificial biological data that forecasts how biological systems will behave during future events. For example, it can predict an athlete’s fatigue level during the remainder of a competition or estimate the likelihood of winning based on their predicted physiological state.
This capability is particularly valuable in athletic contexts, where understanding future performance outcomes or mitigating risks can be game-changing. Whether applied to live competitions, training sessions, or simulated events, SDL’s patented technology enables athletes and third parties to evaluate performance metrics or assess potential risks associated with specific activities.
“We are thrilled with the issuance of this new patent, which further strengthens our position in the AI ecosystem,” said Vivek Khare, Co-Inventor and Head of Technology at SDL. “Our simulation system is designed to predict outcomes related to future biological states using synthetic data. For instance, it can forecast an athlete’s fatigue levels throughout a competition or calculate the probability of victory based on those predictions. Our exclusivity in key areas like synthetic data generation and simulating biological-based outcomes positions us to deliver unprecedented value to partners across sports, insurance, healthcare, and other rapidly growing markets.”
Personalized Insights Through Adaptive Modeling
Beyond predicting athletic performance, SDL’s patented system introduces a groundbreaking method for users to input information into AI models that incorporate domain-specific knowledge. These models generate highly personalized insights, products, and services derived from biological simulations. Examples include tailored treatment plans, exercise regimens, rehabilitation strategies, nutrition programming, pricing models, and guidance for everyday living.
The system employs adaptive modeling techniques that dynamically adjust to individual subjects, ensuring real-time enhancements as new data becomes available. This flexibility allows for continuous refinement and accuracy, making the system not only predictive but also highly responsive to evolving conditions.
“Our patent portfolio underscores our leadership in leveraging AI to develop foundational systems and methods for understanding and quantifying the biological drivers of human performance,” said Mark Gorski, Co-Inventor and CEO of SDL. “This patent represents a major leap forward by enabling AI-based simulations of complex biological responses without relying heavily on real-world data. It opens up exciting opportunities for model training, product development, system testing, and informed decision-making across multiple industries.”
Broad Applications Across Industries
The applications of SDL’s patented technology extend far beyond athletics. In the realm of sports betting, for example, the ability to predict athlete performance with greater accuracy could revolutionize odds-making and fan engagement. Similarly, in healthcare and insurance, the system’s capacity to simulate biological responses and provide personalized recommendations could enhance patient care, risk assessment, and preventive measures.
In eSports, where cognitive and physical performance are increasingly scrutinized, SDL’s technology offers tools to optimize player endurance and focus during high-stakes tournaments. Meanwhile, in longevity research, the ability to model biological processes could pave the way for breakthroughs in aging-related interventions and therapies.
Strategic Importance of the Patent
The issuance of U.S. Patent No. 12,330,047 reinforces SDL’s competitive edge in the burgeoning fields of AI and synthetic data. With exclusivity granted until April 2041, SDL is well-positioned to capitalize on the growing demand for predictive analytics and personalized solutions. Notably, the patent has also been granted in Japan, underscoring its global relevance and potential impact.
This marks SDL’s fifth issued patent in the U.S., contributing to a robust portfolio of 13 active patent families. Each patent reflects the company’s commitment to pushing the boundaries of AI innovation while addressing critical challenges in human performance and health.
Driving Innovation Across High-Growth Markets
As industries increasingly adopt AI and machine learning technologies, SDL’s latest patent highlights its role as a pioneer in leveraging synthetic data to solve real-world problems. By reducing dependencies on real-world data, the company accelerates advancements in model training, product creation, and system testing. This positions SDL as a key enabler of innovation across diverse sectors, from professional sports to healthcare and beyond.
Looking ahead, SDL’s expanding patent portfolio serves as a testament to its vision of transforming how we understand and interact with biological data. With its cutting-edge simulation system now protected under U.S. law, SDL is poised to unlock novel opportunities for partners and stakeholders worldwide.
About Sports Data Labs, Inc.
Sports Data Labs, Inc. (“SDL”) is a venture-backed, award-winning leader in collection, analysis and distribution of real-time human data from sensors and sensing systems, as well as other data sources. SDL provides patented and other proprietary technologies that empower individuals to collect, control, and distribute their personal data, while using artificial intelligence to transform collected data into metrics, insights and predictions for various real-time and on-demand use cases. SDL also provides personal data acquisition and monetization solutions through its proprietary Human Data Marketplace™. For more information, visit www.sportsdatalabs.com.
